ArticleClinical pharmacokinetics2026
Leveraging Model-Informed Drug Development to Predict Asciminib Efficacy in Second-Line Treatment of Chronic Myeloid Leukemia in Chronic Phase.
Sherwin K B Sy et al.PubMed ↗Publisher ↗
No numbers read from the abstract.